Cellebrite DI (CLBT) Net Cash Flow (2020 - 2026)

Cellebrite DI has reported Net Cash Flow for 7 years, with the latest figure at $7.5 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 91.43% year-over-year to $7.5 million in Q2 2026; TTM through Jun 2026 was -$37.4 million, a 153.19% decrease from a year earlier, with the FY2025 full-year figure at -$69.7 million, down 2179.81% from the prior year.
• Net Cash Flow was $7.5 million for Q2 2026 at Cellebrite DI, down from $9.8 million in the prior quarter.
• The five-year high for Net Cash Flow was $102.3 million in Q3 2025, with the low at -$157.0 million in Q4 2025.
• Average Net Cash Flow over 5 years is -$246333.3, with a median of $8.6 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow soared 18040.49% in 2023, then sank 696.71% in 2024.
• Over 5 years, Net Cash Flow stood at $284000.0 in 2022, then jumped by 18040.49% to $51.5 million in 2023, then grew by 10.15% to $56.7 million in 2024, then sank by 376.59% to -$157.0 million in 2025, then surged by 104.75% to $7.5 million in 2026.
• The last three Net Cash Flow figures came in at $7.5 million (Q2 2026), $9.8 million (Q1 2026), and -$157.0 million (Q4 2025), per Business Quant data.